Two Sigma Investments’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,100
Closed -$664K 2636
2021
Q4
$664K Buy
4,100
+300
+8% +$48.2K ﹤0.01% 2957
2021
Q3
$567K Buy
+3,800
New +$790K ﹤0.01% 3139
2021
Q2
Sell
-1,300
Closed -$344K 3998
2021
Q1
$344K Sell
1,300
-1,000
-43% -$282K ﹤0.01% 3230
2020
Q4
$675K Buy
2,300
+1,300
+130% +$333K ﹤0.01% 2291
2020
Q3
$236K Buy
+1,000
New +$227K ﹤0.01% 2715
2019
Q4
Sell
-2,600
Closed -$341K 3614
2019
Q3
$341K Sell
2,600
-2,400
-48% -$312K ﹤0.01% 2866
2019
Q2
$607K Buy
+5,000
New +$593K ﹤0.01% 2345

Other funds holding AMED

Two Sigma Investments's AMED Position: Q2 2024 in Review

Two Sigma Investments sold out of Amedisys (AMED) in Q2 2024, closing a stake of 6,300 shares — an estimated $581K sold.

Two Sigma Investments first reported a position in AMED in Q2 2013 and held it in 33 quarters. The position peaked at $25.1M in Q3 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Two Sigma Investments reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 6,300 Amedisys shares in Q2 2024, an estimated $581K.
  • Two Sigma Investments first reported a position in Amedisys in Q2 2013 and held it in 33 quarters.
  • Two Sigma Investments's Amedisys position peaked at $25.1M in Q3 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.